未登录

K

Kwan Hyung Cho

inje university

H指数:19

被引数:1,048

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Finerenone-loaded self-nanoemulsifying drug delivery system with pH modification for enhanced solubility, stability, dissolution, and bioavailability

含Finerenone的pH修饰型自纳米乳药物递送系统，用于提高溶解度、稳定性、溶出度和生物利用度

Colloids and Surfaces A: Physicochemical and Engineering Aspects

IF5.4

2026-03-070

PRE

Development of selumetinib–loaded solid dispersion based on low molecular weight methylcellulose for the enhanced solubility, stability, dissolution, and bioavailability

基于低分子量甲基纤维素负载塞来替尼的固体分散体的开发，以提高溶解度、稳定性、溶出度和生物利用度

International Journal of Biological Macromolecules

IF8.5

2025-12-080

PRE

Long-acting exendin-4-coated selenium nanoparticles with improved hypoglycemic activity

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2025-01-160

PRE

Supersaturated Gel Formulation (SGF) of Atorvastatin at a Maximum Dose of 80 mg with Enhanced Solubility, Dissolution, and Physical Stability

IF5.3

2024-12-190

OAAI

Supersaturated Liquid Formulation of Pazopanib Hydrochloride Loaded with Synergistic Precipitation Inhibitors

IF4.6

2024-11-071

OAAI

Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant Helicobacter pylori

IF5.5

2024-09-241

OAAI

Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography-Tandem Mass Spectrometry

IF4.6

2024-08-272

OAAI

The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability

开发超饱和瑞巴派特滴眼液，以提高溶解度，稳定性，患者依从性和生物利用度

IF5.5

2023-03-153

OAAI

Paliperidone-Cation Exchange Resin Complexes of Different Particle Sizes for Controlled Release

IF5.5

2023-03-132

OAAI

Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution

IF5.5

2022-09-0513

OAAI

Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-09-018

OAAI

Development of Alectinib-Suspended SNEDDS for Enhanced Solubility and Dissolution

IF5.5

2022-08-1414

OAAI

Combined Application of Prototype Ultrasound and BSA-Loaded PLGA Particles for Protein Delivery (vol 38, pg 1455, 2021)

PHARMACEUTICAL RESEARCH

IF4.3

2021-10-270

OA

Combined Application of Prototype Ultrasound and BSA-Loaded PLGA Particles for Protein Delivery

PHARMACEUTICAL RESEARCH

IF4.3

2021-08-163

PREAI

Synergistic Effect of Growth Factor Releasing Polymeric Nanoparticles and Ultrasound Stimulation on Osteogenic Differentiation

IF5.5

2021-03-277

OAAI

Development of 20(S)-Protopanaxadiol-Loaded SNEDDS Preconcentrate Using Comprehensive Phase Diagram for the Enhanced Dissolution and Oral Bioavailability

IF5.5

2020-04-159

OAAI

Nanotechnology in the arena of cancer immunotherapy

纳米技术在癌症免疫治疗领域的应用

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2020-01-1916

PREAI

Practical approaches on the long-acting injections

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2019-06-0631

PREAI

Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2019-04-2725

PREAI

Development and Evaluation of Poorly Water-Soluble Celecoxib as Solid Dispersions Containing Nonionic Surfactants Using Fluidized-Bed Granulation

IF5.5

2019-03-2031

OAAI